CAL
DCPH

Capital Advisors Ltd’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Capital Advisors Ltd’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-117
Closed -$2K – 1706
2024
Q1 		$2K Hold
117
– – ﹤0.01% 1099
2023
Q4 		$2K Hold
117
– – ﹤0.01% 1071
2023
Q3 		$1K Hold
117
– – ﹤0.01% 1248
2023
Q2 		$2K Hold
117
– – ﹤0.01% 1067
2023
Q1 		$2K Hold
117
– – ﹤0.01% 958
2022
Q4 		$2K Hold
117
– – ﹤0.01% 921
2022
Q3 		$2K Hold
117
– – ﹤0.01% 926
2022
Q2 		$2K Buy
117
+51
+77% +$563 ﹤0.01% 704
2022
Q1 		$1K Buy
+66
New +$561 ﹤0.01% 842

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Capital Advisors Ltd's DCPH Position: Q2 2024 in Review

Capital Advisors Ltd sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 117 shares — an estimated $2K sold.

Capital Advisors Ltd first reported a position in DCPH in Q1 2022 and held it in 9 quarters. The position peaked at $2K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Capital Advisors Ltd reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Capital Advisors Ltd sold 117 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $2K.
  • Capital Advisors Ltd first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
  • Capital Advisors Ltd's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2K in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Capital Advisors Ltd's 13F filing for Q2 2024, filed 25 Jul 2024.